The Saxagliptin Market size is expected to grow at an annual average of 4% during 2022-2028. There are a large number of blood sugar-lowering drugs. Saxagliptin is an oral diabetes medication known as a DPP IV inhibitor. DDP IV inhibitors are enzymes that help inhibit the release of glucagon. Saxagliptin is used to treat diabetes […]
